John G Cagle1, Dawn C Carr2, Seokho Hong1, Sheryl Zimmerman3. 1. University of Maryland, Baltimore, MD, USA. 2. Stanford University, Stanford, CA, USA. 3. University of North Carolina, Chapel Hill, NC, USA.
Abstract
OBJECTIVE: Economic burden on families coping with end-stage cancer remains poorly understood. Advanced malignancy threatens financial stability of families, and interventions are needed to buffer them from impoverishment. This study examined the relationship between subjective and objective assessments of financial burden on families (financial strain and stress, respectively) and identified potentially modifiable factors to inform intervention efforts. METHODS: Using national survey data, we analyzed responses from households that had recently experienced a cancer death; 176 of households provided information on financial strain, and 158 provided data on financial stress. In addition to self-reported appraisals of financial burden, measures assessed elements of the cancer care experience, treatment, symptom burden, work impact, insurance coverage, and demographics. RESULTS: Despite being well insured, approximately a quarter of respondents reported that the cost of care was a major financial burden, and a third used all or most of their savings. Financial strain and stress were moderately positively correlated (r = 0.46, p < 0.01). Higher financial stress scores were negatively correlated with decedent's age at death (r = -0.34, p < 0.01), and minority respondents ('other' race) reported much higher financial stress (M = 4.7; SD = 3.2) than White (M = 0.8; SD = 1.4) or Black (M = 1.6; SD = 2.2) respondents (p < 0.001). Financial burden was also associated with no or limited insurance coverage, changes in employment, severe pain and nausea, and provider interactions during the cancer care experience (e.g., whether the MD paid attention to non-medical factors or having unanswered questions about medications) (p < 0.05 for all). CONCLUSIONS: The cancer care experience, symptoms, and work impact were associated with financial burden and have important implications for research and practice.
OBJECTIVE: Economic burden on families coping with end-stage cancer remains poorly understood. Advanced malignancy threatens financial stability of families, and interventions are needed to buffer them from impoverishment. This study examined the relationship between subjective and objective assessments of financial burden on families (financial strain and stress, respectively) and identified potentially modifiable factors to inform intervention efforts. METHODS: Using national survey data, we analyzed responses from households that had recently experienced a cancer death; 176 of households provided information on financial strain, and 158 provided data on financial stress. In addition to self-reported appraisals of financial burden, measures assessed elements of the cancer care experience, treatment, symptom burden, work impact, insurance coverage, and demographics. RESULTS: Despite being well insured, approximately a quarter of respondents reported that the cost of care was a major financial burden, and a third used all or most of their savings. Financial strain and stress were moderately positively correlated (r = 0.46, p < 0.01). Higher financial stress scores were negatively correlated with decedent's age at death (r = -0.34, p < 0.01), and minority respondents ('other' race) reported much higher financial stress (M = 4.7; SD = 3.2) than White (M = 0.8; SD = 1.4) or Black (M = 1.6; SD = 2.2) respondents (p < 0.001). Financial burden was also associated with no or limited insurance coverage, changes in employment, severe pain and nausea, and provider interactions during the cancer care experience (e.g., whether the MD paid attention to non-medical factors or having unanswered questions about medications) (p < 0.05 for all). CONCLUSIONS: The cancer care experience, symptoms, and work impact were associated with financial burden and have important implications for research and practice.
Authors: K E Covinsky; L Goldman; E F Cook; R Oye; N Desbiens; D Reding; W Fulkerson; A F Connors; J Lynn; R S Phillips Journal: JAMA Date: 1994-12-21 Impact factor: 56.272
Authors: R Sean Morrison; Joan D Penrod; J Brian Cassel; Melissa Caust-Ellenbogen; Ann Litke; Lynn Spragens; Diane E Meier Journal: Arch Intern Med Date: 2008-09-08
Authors: Cathy J Bradley; K Robin Yabroff; Angela B Mariotto; Christopher Zeruto; Quyen Tran; Joan L Warren Journal: J Clin Oncol Date: 2017-01-03 Impact factor: 44.544
Authors: Cheryl K Altice; Matthew P Banegas; Reginald D Tucker-Seeley; K Robin Yabroff Journal: J Natl Cancer Inst Date: 2016-10-20 Impact factor: 13.506
Authors: Karla T Washington; Jacquelyn J Benson; Daphne E Chakurian; Lori L Popejoy; George Demiris; Abigail J Rolbiecki; Debra Parker Oliver Journal: J Hosp Palliat Nurs Date: 2021-06-01 Impact factor: 2.131
Authors: Katrina R Ellis; Kristin Z Black; Stephanie Baker; Carol Cothern; Kia Davis; Kay Doost; Christina Goestch; Ida Griesemer; Fatima Guerrab; Alexandra F Lightfoot; Neda Padilla; Cleo A Samuel; Jennifer C Schaal; Christina Yongue; Eugenia Eng Journal: Fam Community Health Date: 2020 Jul/Sep